{"id":708,"date":"2026-05-16T00:11:56","date_gmt":"2026-05-16T04:11:56","guid":{"rendered":"https:\/\/www.durhampeptides.ca\/post\/buy-tesamorelin-canada-1"},"modified":"2026-09-26T20:02:54","modified_gmt":"2026-09-27T00:02:54","slug":"buy-tesamorelin-canada-1","status":"publish","type":"post","link":"https:\/\/www.durhampeptides.ca\/fr\/post\/buy-tesamorelin-canada-1","title":{"rendered":"Buy Tesamorelin in Canada: The Complete Stabilized GHRH Analog Buyer's Guide"},"content":{"rendered":"<figure><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-191\" src=\"https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/Tesamorelin-10mg-banner-image.png\" alt=\"Buy tesamorelin research peptide Canada Durham Peptides\" width=\"1535\" height=\"1024\" srcset=\"https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/Tesamorelin-10mg-banner-image.png 1535w, https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/Tesamorelin-10mg-banner-image-300x200.webp 300w, https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/Tesamorelin-10mg-banner-image-1024x683.webp 1024w, https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/Tesamorelin-10mg-banner-image-768x512.webp 768w, https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/Tesamorelin-10mg-banner-image-800x534.webp 800w\" sizes=\"(max-width: 1535px) 100vw, 1535px\" \/><\/figure>\n<p>Buy tesamorelin research peptide Canada Durham Peptides<\/p>\n<p><\/p>\n<p>Tesamorelin is one of the most distinctive research peptides in the growth hormone research category \u2014 a stabilized GHRH (growth hormone-releasing hormone) analog with structural modifications that produce specific research properties not found in native GHRH or other related compounds. For Canadian researchers entering growth hormone research, tesamorelin represents one of the better-characterized GHRH analogs with substantial published research and an approved pharmaceutical pathway (separate from the research-use formulation).<\/p>\n<p><\/p>\n<p>This guide covers the research-use tesamorelin purchase decision: what tesamorelin is, the regulatory distinction between approved pharmaceutical tesamorelin and research-use tesamorelin formulations, what to verify before purchasing, and how Durham Peptides' Canadian-domestic supply operates.<\/p>\n<p><\/p>\n<p>The product page is at <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/product-page\/tesamorelin\/\" target=\"_blank\">Durham Peptides Tesamorelin 10mg<\/a><\/u>.<\/p>\n<p><\/p>\n<p>For the foundational research overview, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/what-is-tesamorelin-stabilized-ghrh\/\" target=\"_blank\">What Is Tesamorelin?<\/a><\/u>. For broader category context, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/growth-hormone-peptides-research\/\" target=\"_blank\">Growth Hormone Peptides: A Complete Research Overview<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>The Critical Regulatory Distinction<\/strong><\/p>\n<p><\/p>\n<p>Before discussing research-use tesamorelin specifically:<\/p>\n<p><\/p>\n<p><strong>Pharmaceutical tesamorelin<\/strong> \u2014 A Health Canada and FDA approved pharmaceutical product for specific therapeutic indications (HIV-associated lipodystrophy specifically). Dispensed by prescription, regulated as a pharmaceutical medication.<\/p>\n<p><\/p>\n<p><strong>Research-use tesamorelin<\/strong> \u2014 Research peptide formulations sold for laboratory and research applications under research-use-only framing. Not approved as pharmaceutical products. Sold by research peptide suppliers under research-use framing.<\/p>\n<p><\/p>\n<p><strong>Same chemical structure, two different regulatory categories.<\/strong> The approved pharmaceutical is regulated as a medication for specific therapeutic use. Research-use tesamorelin operates in the research peptide framework. The two products exist in parallel under different regulatory frameworks.<\/p>\n<p><\/p>\n<p>For complete regulatory framework coverage, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/are-peptides-legal-in-canada\/\" target=\"_blank\">Are Peptides Legal in Canada?<\/a><\/u> et <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/are-peptides-illegal-in-canada\/\" target=\"_blank\">Are Peptides Illegal in Canada?<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>What Tesamorelin Is<\/strong><\/p>\n<p><\/p>\n<p>Tesamorelin is a 44-amino-acid synthetic GHRH analog with structural modifications that extend stability:<\/p>\n<ul><li><strong>44 amino acids in length<\/strong> \u2014 same length as native human GHRH(1-44)<\/li><li><strong>N-terminal trans-3-hexenoic acid modification<\/strong> \u2014 the key structural modification that distinguishes tesamorelin from native GHRH<\/li><li><strong>Stabilized against enzymatic degradation<\/strong> \u2014 the modification provides extended stability vs native GHRH<\/li><li><strong>GHRH receptor agonist<\/strong> \u2014 engages the GHRH receptor system to stimulate growth hormone release research<\/li><\/ul>\n<p><\/p>\n<p>The trans-3-hexenoic acid modification at the N-terminus is the key structural feature. Native GHRH is rapidly degraded by enzymes (half-life of approximately 7 minutes), making it impractical for research. The modification protects against the primary degradation site, producing a compound with practical research half-life.<\/p>\n<p>For complete structural coverage, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/what-is-tesamorelin-stabilized-ghrh\/\" target=\"_blank\">What Is Tesamorelin?<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>The Research Mechanism<\/strong><\/p>\n<p>The published research literature on tesamorelin has documented:<\/p>\n<ul><li><strong>GHRH receptor agonism<\/strong> \u2014 direct activation of GHRH receptors in research models<\/li><li><strong>Growth hormone release stimulation<\/strong> \u2014 primary research mechanism<\/li><li><strong>Lipid metabolism research applications<\/strong> \u2014 particularly in visceral adipose tissue research<\/li><li><strong>Cardiovascular research<\/strong> in various models<\/li><li><strong>Stabilized half-life supporting research administration patterns<\/strong> \u2014 the structural modification enables practical research use<\/li><\/ul>\n<p><\/p>\n<p>The growth hormone release mechanism positions tesamorelin in the GH peptide research category alongside other GHRH analogs (sermorelin, CJC-1295), GHRP compounds (ghrelin mimetics like ipamorelin), and related compounds.<\/p>\n<p><\/p>\n<p><strong>Why \"Stabilized GHRH Analog\" Matters<\/strong><\/p>\n<p><\/p>\n<p>The \"stabilized\" qualifier is important for understanding tesamorelin's research positioning:<\/p>\n<p><\/p>\n<p><strong>Native GHRH<\/strong> has a half-life of approximately 7 minutes due to rapid enzymatic degradation. This makes it impractical for most research applications \u2014 the compound clears too quickly to maintain consistent research model concentrations.<\/p>\n<p><\/p>\n<p><strong>Tesamorelin's modification<\/strong> extends the practical half-life substantially. The trans-3-hexenoic acid modification at the N-terminus protects against the primary enzymatic degradation site, producing a compound that supports practical research administration patterns.<\/p>\n<p><\/p>\n<p><strong>Other GHRH analogs<\/strong> use different stabilization approaches:<\/p>\n<ul><li><strong>Sermorelin<\/strong> is the GHRH(1-29) fragment \u2014 shorter sequence, different stability profile<\/li><li><strong>CJC-1295<\/strong> uses different modifications including DAC (drug affinity complex) for albumin binding<\/li><\/ul>\n<p><\/p>\n<p>Each compound in the GHRH analog category has distinct structural features that produce distinct research properties. For complete comparison, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/tesamorelin-vs-cjc-1295-vs-sermorelin\/\" target=\"_blank\">Tesamorelin vs CJC-1295 vs Sermorelin: GHRH Analog Comparison<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>What to Verify Before Buying Research-Use Tesamorelin<\/strong><\/p>\n<p><\/p>\n<p>The standard six-criteria framework applies particularly stringently to tesamorelin due to:<\/p>\n<ol><li>The structural modification (trans-3-hexenoic acid at N-terminus) requires specialized synthesis chemistry<\/li><li>Identity verification needs to confirm both the peptide backbone AND the modification<\/li><li>Pharmaceutical-grade comparison creates market interest that low-quality suppliers may try to exploit<\/li><\/ol>\n<p><\/p>\n<p><strong>Criterion 1: Independent third-party COA via Janoshik Analytical.<\/strong> Research-use tesamorelin should have a <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/how-to-verify-janoshik-coa\/\" target=\"_blank\">Janoshik<\/a><\/u>Certificate of Analysis publicly accessible. For Durham Peptides Tesamorelin 10mg, the COA is at <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/lab-results\/\" target=\"_blank\" rel=\"noreferrer\">durhampeptides.ca\/lab-results<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Criterion 2: \u226599% HPLC purity.<\/strong> Research-grade standard. See <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/what-is-hplc-testing-for-peptides\/\" target=\"_blank\">What Is HPLC Testing for Peptides?<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Criterion 3: Mass spectrometry identity confirmation.<\/strong> Particularly important for tesamorelin due to the structural modification. MS should confirm the molecular weight matches the modified compound's expected value (approximately 5135 Da). The mass difference between native GHRH(1-44) and tesamorelin reflects the trans-3-hexenoic acid modification. See <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/how-to-read-mass-spectrometry-coa\/\" target=\"_blank\">How to Read Mass Spectrometry Data on a Peptide COA<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Criterion 4: Solid-Phase Peptide Synthesis manufacturing with specialized chemistry for the N-terminal modification.<\/strong> Modern synthetic chemistry. See <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/peptide-manufacturing-process\/\" target=\"_blank\">Peptide Manufacturing 101<\/a><\/u> et <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/vegan-peptides-canada\/\" target=\"_blank\">Vegan Peptides<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Criterion 5: Canadian-domestic supply<\/strong> under research-use-only framing.<\/p>\n<p><\/p>\n<p><strong>Criterion 6: Research-use-only framing maintained consistently.<\/strong> Suppliers approaching therapeutic claims (suggesting tesamorelin substitutes for an approved pharmaceutical, claiming therapeutic equivalence) operate outside the research-use framework. See <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/peptide-supplier-red-flags\/\" target=\"_blank\">Peptide Supplier Red Flags<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Why Identity Verification Matters Especially for Tesamorelin<\/strong><\/p>\n<p><\/p>\n<p>Three specific factors make identity verification particularly important:<\/p>\n<p><\/p>\n<p><strong>1. The modification matters.<\/strong> A \"tesamorelin\" product that's actually unmodified GHRH(1-44) is essentially a different compound with dramatically different stability. Mass spectrometry identity confirmation catches this.<\/p>\n<p><\/p>\n<p><strong>2. Manufacturing complexity creates quality variation.<\/strong> The N-terminal trans-3-hexenoic acid modification requires specialized synthesis chemistry. Suppliers cutting corners produce products with incorrect modifications.<\/p>\n<p><\/p>\n<p><strong>3. Pharmaceutical comparison creates market pressure.<\/strong> Suppliers may try to satisfy demand from researchers searching for pharmaceutical alternatives by selling lower-quality tesamorelin or mislabeled products.<\/p>\n<p><\/p>\n<p>The verifiable Janoshik COA with mass spectrometry identity confirmation addresses all three factors.<\/p>\n<p><\/p>\n<p><strong>Reconstitution and Storage<\/strong><\/p>\n<p><\/p>\n<p>Tesamorelin follows the standard research peptide reconstitution and storage framework:<\/p>\n<p><\/p>\n<p><strong>Reconstitution.<\/strong> Use <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/product-page\/bacteriostatic-water-10ml\/\" target=\"_blank\">eau bact\u00e9riostatique<\/a><\/u>. For 10mg vial: common reconstitution is 1mL bacteriostatic water \u2192 10 mg\/mL concentration. For complete math, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/peptide-reconstitution-math-step-by-step\/\" target=\"_blank\">Peptide Reconstitution Math Step-by-Step<\/a><\/u>. For visual reference, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/peptide-reconstitution-chart\/\" target=\"_blank\">Peptide Reconstitution Chart<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Storage.<\/strong> Lyophilized vials refrigerated (2-8\u00b0C) for moderate-term, frozen (-20\u00b0C) for long-term. Reconstituted vials refrigerated only, used within ~28 days. See <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/peptide-storage-shelf-life-guide\/\" target=\"_blank\">Peptide Storage &amp; Shelf Life<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Quality at Durham Peptides<\/strong><\/p>\n<p><\/p>\n<p>For Durham Peptides Tesamorelin 10mg:<\/p>\n<ul><li>Manufactured via Solid-Phase Peptide Synthesis with synthetic amino acids<\/li><li>N-terminal trans-3-hexenoic acid modification incorporated through specialized synthesis<\/li><li>No animal-derived materials<\/li><li>Independent third-party testing by <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/how-to-verify-janoshik-coa\/\" target=\"_blank\">Janoshik Analytical<\/a><\/u><\/li><li>\u226599% HPLC purity verified<\/li><li>Mass spectrometry identity confirmation including modification mass<\/li><li>Verifiable Janoshik unique key<\/li><li>Canadian-domestic supply with same-day Ontario shipping<\/li><li>Canadian-dollar pricing<\/li><li>Research-use-only framing throughout<\/li><\/ul>\n<p><\/p>\n<p><strong>Canadian-Domestic Supply Advantages<\/strong><\/p>\n<p><\/p>\n<p>For tesamorelin specifically, Canadian-domestic supply provides:<\/p>\n<ul><li>No customs uncertainty (domestic shipment)<\/li><li>Canadian-dollar pricing<\/li><li>Same-day Ontario shipping with 2-5 business day Canadian delivery<\/li><li>No import duties or GST on imports<\/li><li>Verifiable Canadian business operations<\/li><\/ul>\n<p><\/p>\n<p>For complete shipping context, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/peptide-shipping-canada-complete-guide\/\" target=\"_blank\">Peptide Shipping in Canada<\/a><\/u>. For complete buyer's framework, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/how-to-buy-peptides-canada-2026\/\" target=\"_blank\">How to Buy Peptides in Canada<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Research Applications<\/strong><\/p>\n<p>The published research on tesamorelin suggests research applications focused on:<\/p>\n<ul><li><strong>Growth hormone release research<\/strong> \u2014 primary research category<\/li><li><strong>GHRH receptor mechanism research<\/strong> \u2014 receptor pharmacology studies<\/li><li><strong>Lipid metabolism research<\/strong> \u2014 particularly visceral adipose tissue research, given the approved pharmaceutical indication<\/li><li><strong>Cardiovascular research<\/strong> in various models<\/li><li><strong>Stabilized peptide research<\/strong> \u2014 tesamorelin as a model for understanding how stability modifications affect research properties<\/li><\/ul>\n<p><\/p>\n<p>For broader growth hormone peptide research context, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/growth-hormone-peptides-research\/\" target=\"_blank\">Growth Hormone Peptides: A Complete Research Overview<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Questions fr\u00e9quentes<\/strong><\/p>\n<p><\/p>\n<p><strong>What is tesamorelin?<\/strong> A 44-amino-acid synthetic GHRH analog with N-terminal trans-3-hexenoic acid modification that provides stability against enzymatic degradation. Studied as a GHRH receptor agonist for growth hormone release research.<\/p>\n<p><\/p>\n<p><strong>Is tesamorelin a GHRH analog?<\/strong> Yes. Tesamorelin is structurally based on native human GHRH(1-44) with a specific N-terminal modification that extends stability.<\/p>\n<p><\/p>\n<p><strong>Does Durham Peptides sell tesamorelin?<\/strong> Yes. <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/product-page\/tesamorelin\/\" target=\"_blank\">Tesamorelin 10mg<\/a><\/u> is available as a research peptide with full Janoshik third-party testing and Canadian-domestic shipping.<\/p>\n<p><\/p>\n<p><strong>Is research-use tesamorelin the same as the approved pharmaceutical?<\/strong> The chemical structure is the same. The regulatory category is different. The approved pharmaceutical is a Health Canada product dispensed by prescription for HIV-associated lipodystrophy. Research-use tesamorelin is sold under research-use-only framing for laboratory and research applications.<\/p>\n<p><\/p>\n<p><strong>Is research-use tesamorelin legal in Canada?<\/strong> Operates under the research-use-only framework \u2014 sold for laboratory and research applications. See <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/are-peptides-legal-in-canada\/\" target=\"_blank\">Are Peptides Legal in Canada?<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Is tesamorelin tested?<\/strong> Yes. Durham Peptides Tesamorelin 10mg is independently tested by <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/how-to-verify-janoshik-coa\/\" target=\"_blank\">Janoshik Analytical<\/a><\/u> with verifiable COA at <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/lab-results\/\" target=\"_blank\" rel=\"noreferrer\">durhampeptides.ca\/lab-results<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Is tesamorelin vegan?<\/strong> Yes. Manufactured via SPPS with synthetic amino acids \u2014 no animal-derived materials. The trans-3-hexenoic acid modification uses synthetic chemistry. See <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/vegan-peptides-canada\/\" target=\"_blank\">Vegan Peptides<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>What's tesamorelin's research mechanism?<\/strong> GHRH receptor agonism with growth hormone release stimulation in research models. The stabilizing modification extends practical half-life vs native GHRH.<\/p>\n<p><\/p>\n<p><strong>How is tesamorelin different from CJC-1295?<\/strong> Different modifications producing different research properties. Tesamorelin has N-terminal trans-3-hexenoic acid; CJC-1295 has different modifications including (in CJC-1295 with DAC) drug affinity complex for albumin binding. See <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/tesamorelin-vs-cjc-1295-vs-sermorelin\/\" target=\"_blank\">Tesamorelin vs CJC-1295 vs Sermorelin<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>How is tesamorelin different from sermorelin?<\/strong> Sermorelin is the GHRH(1-29) fragment \u2014 shorter sequence. Tesamorelin is GHRH(1-44) with the trans-3-hexenoic acid modification \u2014 full-length stabilized compound. Different stability profiles and research properties.<\/p>\n<p><\/p>\n<p><strong>What's tesamorelin's shelf life?<\/strong> Approximately 12-18 months refrigerated, 24+ months frozen for the lyophilized form. Approximately 28 days under refrigeration after reconstitution.<\/p>\n<p><\/p>\n<p><strong>How fast does tesamorelin ship in Canada?<\/strong> Same-day Ontario shipping with typical 2-5 business day delivery across Canada.<\/p>\n<p><\/p>\n<p><strong>Why is tesamorelin in the growth hormone peptide category?<\/strong> The GHRH receptor agonism mechanism stimulates growth hormone release in research models. This positions tesamorelin in the broader GH peptide research category alongside other GHRH analogs and GHRP compounds.<\/p>\n<p><\/p>\n<p><strong>Final Thoughts<\/strong><\/p>\n<p><\/p>\n<p>Research-use tesamorelin is one of the more distinctive research peptides in the growth hormone category \u2014 a stabilized GHRH analog with substantial published research, an approved pharmaceutical pathway (separate from research-use), and specific structural features that distinguish it from other GHRH analogs. For Canadian researchers entering growth hormone research, tesamorelin represents one of the better-characterized GHRH analogs available in the Canadian-domestic research peptide market.<\/p>\n<p>For Canadian researchers, the practical takeaways:<\/p>\n<p><\/p>\n<ol><li>Tesamorelin = 44-amino-acid GHRH analog with N-terminal trans-3-hexenoic acid modification<\/li><li>Research-use tesamorelin and approved pharmaceutical tesamorelin are different regulatory categories of the same chemical<\/li><li>Identity verification (mass spectrometry) is particularly important due to the structural modification<\/li><li>Available as <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/product-page\/tesamorelin\/\" target=\"_blank\">Tesamorelin 10mg<\/a><\/u> with Canadian-domestic shipping<\/li><li>Janoshik third-party testing applies as quality verification standard<\/li><\/ol>\n<p><\/p>\n<p>For continued reading, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/what-is-tesamorelin-stabilized-ghrh\/\" target=\"_blank\">What Is Tesamorelin?<\/a><\/u>, <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/tesamorelin-vs-cjc-1295-vs-sermorelin\/\" target=\"_blank\">Tesamorelin vs CJC-1295 vs Sermorelin<\/a><\/u>, <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/growth-hormone-peptides-research\/\" target=\"_blank\">Growth Hormone Peptides: A Complete Research Overview<\/a><\/u>, <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/are-peptides-legal-in-canada\/\" target=\"_blank\">Are Peptides Legal in Canada?<\/a><\/u>, et <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/how-to-buy-peptides-canada-2026\/\" target=\"_blank\">How to Buy Peptides in Canada<\/a><\/u>.<\/p>\n<p><\/p>\n<p>Browse the complete Durham Peptides catalog at <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/category\/all-products\/\" target=\"_blank\" rel=\"noreferrer\">durhampeptides.ca\/category\/all-products<\/a><\/u>. View all Janoshik-verified COAs at <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/lab-results\/\" target=\"_blank\" rel=\"noreferrer\">durhampeptides.ca\/lab-results<\/a><\/u>.<\/p>\n<p><\/p>\n<p><strong>Selected References<\/strong><\/p>\n<p><\/p>\n<ol><li>Falutz J, Allas S, Blot K, et al. Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIV. <em>New England Journal of Medicine<\/em>. 2007;357(23):2359-2370. <u><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18057338\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/18057338\/<\/a><\/u><\/li><li>Adrian S, Scherzer R, Snyder CC, et al. The Growth Hormone Axis as a Therapeutic Target in Atherosclerosis. <em>Endocrinology and Metabolism Clinics of North America<\/em>. 2019;48(3):599-610. <u><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31345526\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31345526\/<\/a><\/u><\/li><li>Stanley TL, Falutz J, Marsolais C, et al. Reduction in Visceral Adiposity Is Associated with an Improved Metabolic Profile in HIV-Infected Patients Receiving Tesamorelin. <em>Clinical Infectious Diseases<\/em>. 2012;54(11):1642-1651. <u><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22495074\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/22495074\/<\/a><\/u><\/li><li>Frohman LA, Kineman RD. Growth Hormone-Releasing Hormone and Pituitary Development, Hyperplasia and Tumorigenesis. <em>Trends in Endocrinology and Metabolism<\/em>. 2002;13(7):299-303. <u><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12163233\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/12163233\/<\/a><\/u><\/li><li>Veldhuis JD, Bowers CY. Human GH Pulsatility: An Ensemble Property Regulated by Age and Gender. <em>Journal of Endocrinological Investigation<\/em>. 2003;26(9):799-813. <u><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14964431\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/14964431\/<\/a><\/u><\/li><li>Government of Canada. <em>Food and Drugs Act<\/em> (R.S.C., 1985, c. F-27). Canadian statutory framework governing pharmaceutical products.<\/li><\/ol>\n<p><\/p>\n<p><em>All products sold by Durham Peptides are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease. This article is informational and does not constitute medical advice.<\/em><\/p>","protected":false},"excerpt":{"rendered":"Buy tesamorelin research peptide Canada Durham Peptides Tesamorelin is one of the most distinctive research peptides in the growth hormone research category \u2014 a stabilized GHRH (growth hormone-releasing hormone) analog with structural modifications that produce specific research properties not found in native GHRH or other related compounds. For Canadian researchers entering growth hormone research, tesamorelin represents one of the better-characterized GHRH analogs with substantial published...","protected":false},"author":1,"featured_media":191,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[56],"tags":[],"class_list":["post-708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-buying-guides"],"_links":{"self":[{"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/posts\/708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/comments?post=708"}],"version-history":[{"count":1,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/posts\/708\/revisions"}],"predecessor-version":[{"id":1049,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/posts\/708\/revisions\/1049"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/media\/191"}],"wp:attachment":[{"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/media?parent=708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/categories?post=708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/tags?post=708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}